Editorial Type:
Ophthalmology

Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs

Jean-Yves Douet Département des sciences cliniques, INP-Ecole nationale vétérinaire, 31076 Toulouse Cedex 3, France.

Search for other papers by Jean-Yves Douet in
Current site
Google Scholar
PubMed Close
 Dr Med Vet
,
Julien Michel Département des sciences cliniques, INP-Ecole nationale vétérinaire, 31076 Toulouse Cedex 3, France.

Search for other papers by Julien Michel in
Current site
Google Scholar
PubMed Close
 Dr Med Vet
, and
Alain Regnier Département des sciences cliniques, INP-Ecole nationale vétérinaire, 31076 Toulouse Cedex 3, France.

Search for other papers by Alain Regnier in
Current site
Google Scholar
PubMed Close
 Dr Med Vet, PhD
DOI:
https://doi.org/10.2460/ajvr.74.10.1321
Volume/Issue:
Volume 74: Issue 10
Online Publication Date:
01 Oct 2013
Restricted access
Sign In Reprints and Permissions Purchase Article

Abstract

Objective—To assess the anesthetic efficacy and local tolerance of topically applied 0.4% oxybuprocaine ophthalmic solution to in dogs and compare its effects with those of 1% tetracaine solution.

Animals—34 ophthalmically normal Beagles.

Procedures—Dogs were assigned to 2 groups, and baseline corneal touch threshold (CTT) was measured bilaterally with a Cochet-Bonnet aesthesiometer. Dogs of group 1 (n = 22) received a single drop of 0.4% oxybuprocaine ophthalmic solution in one eye and saline (0.9% NaCl) solution (control treatment) in the contralateral eye. Dogs of group 2 (n = 12) received a single drop of 0.4% oxybuprocaine ophthalmic solution in one eye and 1% tetracaine ophthalmic solution in the contralateral eye. The CTT of each eye was measured 1 and 5 minutes after topical application and then at 5-minute intervals until 75 minutes after topical application.

Results—CTT changes over time differed significantly between oxybuprocaine-treated and control eyes. After instillation of oxybuprocaine, maximal corneal anesthesia (CTT = 0) was achieved within 1 minute, and CTT was significantly decreased from 1 to 45 minutes, compared with the baseline value. No significant difference in onset, depth, and duration of corneal anesthesia was found between oxybuprocaine-treated and tetracaine-treated eyes. Conjunctival hyperemia and chemosis were detected more frequently in tetracaine-treated eyes than in oxybuprocaine-treated eyes.

Conclusions and Clinical Relevance—Topical application of oxybuprocaine and tetracaine similarly reduced corneal sensitivity in dogs, but oxybuprocaine was less irritating to the conjunctiva than was tetracaine.

Abstract

Objective—To assess the anesthetic efficacy and local tolerance of topically applied 0.4% oxybuprocaine ophthalmic solution to in dogs and compare its effects with those of 1% tetracaine solution.

Animals—34 ophthalmically normal Beagles.

Procedures—Dogs were assigned to 2 groups, and baseline corneal touch threshold (CTT) was measured bilaterally with a Cochet-Bonnet aesthesiometer. Dogs of group 1 (n = 22) received a single drop of 0.4% oxybuprocaine ophthalmic solution in one eye and saline (0.9% NaCl) solution (control treatment) in the contralateral eye. Dogs of group 2 (n = 12) received a single drop of 0.4% oxybuprocaine ophthalmic solution in one eye and 1% tetracaine ophthalmic solution in the contralateral eye. The CTT of each eye was measured 1 and 5 minutes after topical application and then at 5-minute intervals until 75 minutes after topical application.

Results—CTT changes over time differed significantly between oxybuprocaine-treated and control eyes. After instillation of oxybuprocaine, maximal corneal anesthesia (CTT = 0) was achieved within 1 minute, and CTT was significantly decreased from 1 to 45 minutes, compared with the baseline value. No significant difference in onset, depth, and duration of corneal anesthesia was found between oxybuprocaine-treated and tetracaine-treated eyes. Conjunctival hyperemia and chemosis were detected more frequently in tetracaine-treated eyes than in oxybuprocaine-treated eyes.

Conclusions and Clinical Relevance—Topical application of oxybuprocaine and tetracaine similarly reduced corneal sensitivity in dogs, but oxybuprocaine was less irritating to the conjunctiva than was tetracaine.

Contributor Notes

Presented in part at the Annual Meeting of the European College of Veterinary Ophthalmologists, Trieste, Italy, May 2012.

Address correspondence to Dr. Regnier (a.regnier@envt.fr).
Cover American Journal of Veterinary Research
American Journal of Veterinary Research
Publication Date:
01 Oct 2013

  • 1. Collins BK, Gross ME, Moore CP, et al. Physiologic, pharmacologic, and practical considerations for anesthesia of domestic animals with eye disease. J Am Vet Med Assoc 1995; 207:220–230.

    • Search Google Scholar
    • Export Citation

  • 2. Herring IP. Mydriatics/cycloplegics, anesthetics, ophthalmic dyes, tear substitutes and stimulators, intraocular irrigating agents, topical disinfectants, viscoelastics, fibrinolytics and antifibrinolytics, antifibrotic agents, tissue adhesives, and anticollagenase agents. In: Gelatt KN, ed. Veterinary ophthalmology. 4th ed. Ames, Iowa: Blackwell Publishing, 2007;332–354.

    • Search Google Scholar
    • Export Citation

  • 3. Ellis FD. Topical and local anesthetic agents. In: Zimmerman TJ, Kooner KS, Sharir M, et al., eds. Textbook of ocular pharmacology. Philadelphia: Lippincott-Raven, 1997;791–793.

    • Search Google Scholar
    • Export Citation

  • 4. Catterall WA, Mackie K. Local anesthetics. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw Hill Medical, 2010;565–582.

    • Search Google Scholar
    • Export Citation

  • 5. Butterworth JF, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology 1990; 72:711–734.

  • 6. Hasan SA, Edelhauser HF, Kim T II. Topical/intracameral anesthesia for cataract surgery. Surv Ophthalmol 2001; 46:178–181.

  • 7. Jackson T, McLure HA. Pharmacology of local anesthetics. Ophthalmol Clin North Am 2006; 19:155–161.

  • 8. McGee HT, Fraunfelder FW. Toxicities of topical ophthalmic anesthetics. Expert Opin Drug Saf 2007; 6:637–640.

  • 9. Pucket JD, Allbaugh RA, Rankin AJ, et al. Comparison of efficacy and duration of effect on corneal sensitivity among anesthetic agents following ocular administration in clinically normal horses. Am J Vet Res 2013; 74:459–464.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 10. Gelatt KN. Anesthetic agents. In: Gelatt KN, ed. Veterinary ophthalmic pharmacology and therapeutics. 2nd ed. Bonner Springs, Kan: VM Publishing Inc, 1987;23–28.

    • Search Google Scholar
    • Export Citation

  • 11. Bartfield JM, Holmes TJ, Raccio-Robak N. A comparison of proparacaine and tetracaine eye anesthetics. Acad Emerg Med 1994; 1:364–367.

    • Search Google Scholar
    • Export Citation

  • 12. Parchen HD, Izar ML, Branco PS, et al. Ophthalmic and anesthetic evaluation of topical 1% tetracaine and 0.5% proparacaine in dogs. Arq Bras Med Vet Zootec 2011; 63:1337–1344.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 13. Sharrow-Reabe KL, Townsend WM. Effects of action of proparacaine and tetracaine topical ophthalmic formulations on corneal sensitivity in horses. J Am Vet Med Assoc 2012; 241:1645–1649.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 14. Schlegel HE Jr, Swan KC. Benoxinate (dorsacaine) for rapid corneal anesthesia. AMA Arch Ophthalmol 1954; 51:663–670.

  • 15. Emmerich R, Carter GZ, Berens C. An experimental clinical evaluation of dorsacaine hydrochloride (benoxinate novesine); report on the instillation of a 0.4-percent solution. Am J Ophthalmol 1955; 40:841–848.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 16. Linn JG Jr, Vey EK. Topical anesthesia in ophthalmology. Am J Ophthalmol 1955; 40:697–704.

  • 17. Gandhi SS. Local anesthetics. In: Lamberts DW, Potter DE, eds. Clinical ophthalmic pharmacology. Boston: Little, Brown and Co, 1987;335–359.

    • Search Google Scholar
    • Export Citation

  • 18. Than TP, Bartlett JD. Local anesthetics. In: Lamberts DW, Potter DE, eds. Clinical ocular pharmacology. 5th ed. St Louis: Butterworth-Heinemann, 2008;85–95.

    • Search Google Scholar
    • Export Citation

  • 19. Recep OF, Hasiripi H, Vayisoglu E, et al. Accurate time interval in repeated tonometry. Acta Ophthalmol Scand 1998; 76:603–605.

  • 20. Lytle J, Thomas NF. Haemodynamic stability during general anaesthesia for intra-ocular surgery: the effect of topical oxybuprocaine. Anaesthesia 1992; 47:616–617.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 21. Perez-Gomez I, Hollingsworth J, Efron N. Effects of benoxinate hydrochloride 0.4% on the morphological appearance of the cornea using confocal microscopy. Cont Lens Anterior Eye 2004; 27:45–48.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 22. Tonnu PA, Ho T, Sharma K, et al. A comparison of four methods of tonometry: method agreement and interobserver variability. Br J Ophthalmol 2005; 89:847–850.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 23. Moesen I, Duncan M, Cates C, et al. Nitrous oxide cryotherapy for primary periocular basal cell carcinoma: outcome at 5 years follow-up. Br J Ophthalmol 2011; 95:1679–1681.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 24. Wallin-Håkanson N, Wallin-Håkanson B. The effects of topical tropicamide and systemic medetomidine, followed by atipamezole reversal, on pupil size and intraocular pressure in normal dogs. Vet Ophthalmol 2001; 4:3–6.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 25. Regnier A, Lemagne C, Ponchet A, et al. Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes. Vet Ophthalmol 2006; 9:39–43.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 26. Cochet P, Bonnet R. Corneal esthesiometry. Performance and practical importance. Bull Soc Ophtalmol Fr 1961; 6:541–550.

  • 27. Belmonte C, Garcia-Hirschfeld J, Gallar J. Neurobiology of ocular pain. Prog Retin Eye Res 1997; 16:117–156.

  • 28. Barrett PM, Scagliotti RH, Meredith RE, et al. Absolute corneal sensitivity and corneal trigeminal nerve anatomy in normal dogs. Vet Comp Ophthalmol 1991; 1:245–254.

    • Search Google Scholar
    • Export Citation

  • 29. Good KL, Maggs DJ, Hollingsworth SR, et al. Corneal sensitivity in dogs with diabetes mellitus. Am J Vet Res 2003; 64:7–11.

  • 30. Ollivier FJ, Plummer CE, Barrie KP. The eye examination and diagnostic procedure. In: Gelatt KN, ed. Veterinary ophthalmology. 4th ed. Ames, Iowa: Blackwell Publishing, 2007;438–483.

    • Search Google Scholar
    • Export Citation

  • 31. Wieser B, Tichy A, Nell B. Correlation between corneal sensitivity and quantity of reflex tearing in cows, horses, goats, sheep, dogs, cats, rabbits, and guinea pigs. Vet Ophthalmol 2013; 16:251–262.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 32. Von Frey M. Die Sensibilität der Hornhaut und Bindehaut des menschlichen Auges. Dtsch Med Wochenschr 1922; 48:212–225.

  • 33. Murphy PJ, Blades KJ, Patel S. Effect of 0.4% benoxinate hydrochloride on corneal sensitivity, measured using the non-contact corneal aesthesiometer (NCCA). Optom Vis Sci 1997; 74:1025–1029.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 34. Millodot M, O'Leary DJ. Effect of oxygen deprivation on corneal sensitivity. Acta Ophthalmol (Copenh) 1980; 58:434–439.

  • 35. Herring IP, Bobofchak MA, Landry MP, et al. Duration of effect and effect of multiple doses of topical ophthalmic 0.5% proparacaine hydrochloride in clinically normal dogs. Am J Vet Res 2005; 66:77–80.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 36. Binder DR, Herring IP. Duration of corneal anesthesia following topical administration of 0.5% proparacaine hydrochloride solution in clinically normal cats. Am J Vet Res 2006; 67:1780–1782.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 37. Kalf KL, Utter ME, Wotman KL. Evaluation of duration of corneal anesthesia induced with ophthalmic 0.5% proparacaine hydrochloride by use of a Cochet-Bonnet aesthesiometer in clinically normal horses. Am J Vet Res 2008; 69:1655–1658.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 38. Wotman KL, Utter ME. Effect of treatment with a topical ophthalmic preparation of 1% nalbuphine solution on corneal sensitivity in clinically normal horses. Am J Vet Res 2010; 71:223–228.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 39. Monclin SJ, Farnir F, Grauwels M. Duration of corneal anaesthesia following multiple doses and two concentrations of tetracaine hydrochloride eyedrops on the normal equine cornea. Equine Vet J 2011; 43:69–73.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 40. Oldham GB, Andrews V. Control of microbial contamination in unpreserved eyedrops. Br J Ophthalmol 1996; 80:588–591.

  • 41. Lawrenson JG, Edgar DF, Tanna GK, et al. Comparison of the tolerability and efficacy of unit-dose, preservative-free topical ocular anaesthetics. Ophthalmic Physiol Opt 1998; 18:393–400.

    • Crossref
    • Search Google Scholar
    • Export Citation

  • 42. Millodot M, Larson W. Effect of bending of the nylon thread of the Cochet-Bonnet corneal aesthesiometer upon the recorded pressure. Contact Lens 1967; 1:5–7.

    • Search Google Scholar
    • Export Citation

  • 43. Kolstad A. Corneal sensivity by low temperatures. Acta Ophthalmol (Copenh) 1970; 48:789–793.

  • 44. Polse KA, Keener RJ, Jauregui MJ. Dose-response effects of corneal anesthetics. Am J Optom Physiol Opt 1978; 55:8–14.

  • 45. Koch SA, Rubin LF. Ocular sensitivity of dogs to topical tetracaine HCl. J Am Vet Med Assoc 1969; 154:15–16.

  • 46. Rubin LF, Gelatt KN. Corneal epithelial sloughing in dogs with glaucoma. J Am Vet Med Assoc 1967; 151:1449–1452.

  • 47. German EJ, Hurst MA, Wood D. Eye drop container delivery: a source of response variation? Ophthalmic Physiol Opt 1997; 17:196–204.

  • 48. German EJ, Hurst MA, Wood D. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern? Eye (Lond) 1999; 13:93–100.

  • 49. Van Santvliet L, Ludwig A. Determinants of eye drop size. Surv Ophthalmol 2004; 49:197–213.

Advertisement